Guardant Health Inc logo

Guardant Health Inc

1
1
NAS:GH (USA)  
$ 29.54 0 (0%) 11:09 PM EST
At Loss
P/B:
52.66
Volume:
1.32M
Avg Vol (2M):
2.38M
Trade In:
Volume:
1.32M
At Loss
Avg Vol (2M):
2.38M

Business Description

Guardant Health Inc logo
Guardant Health Inc
NAICS : 621511 SIC : 8071
ISIN : US40131M1099
Description
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Name Current Vs Industry Vs History
Cash-To-Debt 0.84
Equity-to-Asset 0.04
Debt-to-Equity 19.73
Debt-to-EBITDA -3.25
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.29
Distress
Grey
Safe
Beneish M-Score -2.83
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.53
9-Day RSI 54.79
14-Day RSI 59.5
6-1 Month Momentum % -13.66
12-1 Month Momentum % -35.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.95
Quick Ratio 5.66
Cash Ratio 5.13
Days Inventory 94.27
Days Sales Outstanding 52.7
Days Payable 95.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.7
Shareholder Yield % 0.45

Financials (Next Earnings Date:2024-08-02 Est.)

GH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Guardant Health Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 603.725
EPS (TTM) ($) -3.92
Beta 1.32
Volatility % 71.54
14-Day RSI 59.5
14-Day ATR ($) 1.344691
20-Day SMA ($) 29.011
12-1 Month Momentum % -35.53
52-Week Range ($) 15.81 - 41.06
Shares Outstanding (Mil) 122.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Guardant Health Inc Filings

Filing Date Document Date Form
No Filing Data

Guardant Health Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Guardant Health Inc Frequently Asked Questions

What is Guardant Health Inc(GH)'s stock price today?
The current price of GH is $29.54. The 52 week high of GH is $41.06 and 52 week low is $15.81.
When is next earnings date of Guardant Health Inc(GH)?
The next earnings date of Guardant Health Inc(GH) is 2024-08-02 Est..
Does Guardant Health Inc(GH) pay dividends? If so, how much?
Guardant Health Inc(GH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1